| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |